T 1698/21 (ANTIVIRAL THERAPY/VIIV Healthcare Company) of 02.10.2024
- European Case Law Identifier
- ECLI:EP:BA:2024:T169821.20241002
- Date of decision
- 2 October 2024
- Case number
- T 1698/21
- Petition for review of
- -
- Application number
- 16187411.0
- IPC class
- A61K 31/52A61K 31/5365A61P 31/18
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- ANTIVIRAL THERAPY
- Applicant name
- VIIV Healthcare Company
- Opponent name
- Cooke, Richard
Sandoz AG
Teva Pharmaceutical Industries Ltd
STADA Arzneimittel AG - Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)European Patent Convention Art 56European Patent Convention Art 76(1)European Patent Convention Art 83European Patent Convention Art 87(1)
- Keywords
- Amendments - allowable (yes)
Sufficiency of disclosure - (yes)
Priority - validity of priority date (yes)
Inventive step - main request (yes) - Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The appeals are dismissed.